Emily Chew

Deputy Director, Division of Epidemiology and Clinical Applications and Deputy Clinical Director at the National Eye Institute, National Institutes of Health, Bethesda, Maryland

Chew is chair of the AREDS2 study and participates in the Actions to Control Cardiovascular Risk in Diabetes trial. Her interest in the ocular complications of von Hippel-Lindau disease has also led her to collaborate with researchers in order to increase the number of clinical trials investigating this rare disease. A medical retinal specialist with extensive experience in the design and implementation of clinical trials across all phases, her principal research interests are diabetic- and age-related eye diseases.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016